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LITTLE is known about the cell surface. Until recently it was thought to be
only the coating ofthe cell, just as the skin was the envelope ofthe body, and was
believed to be only of structural significance. Recently the skin has gained
status as an organ, and the cell surface is now under detailed investigation.
Robertson (1960) investigated the structure of the cell membrane and the
endoplasm, which he found to be a continuous reticulum of the cell. From his
electron microscope studies he has suggested a compound membrane of four
layers, which may consist of a protein monolayer on one side of a lipid core, and
perhaps carbohydrate on the other side, in some cases; Dourmashkin, Dougherty
and Harris (1962) have demonstrated electron microscope studies of red blood
cells which show plaques 40 A by 250 diameter, composed of lecithin and choles-
terol with protein fibres 20 by 100-200 A long lying beneath the plaques. There
is also found to be a surface area ofthe cell which consists of a thin layer of cyto-
plasm which is a poor conductor of electricity (Jacobs, 1962), while the interior
of the cell is a good conductor. Also substances which are unable to diffuse
across the cell membranes, diffuse readily if they are injected into the cell
(Chambers, 1922).
The surface membranes are not homogeneous, but have specialised areas with
regulators of the cell uptake lying in, or on, the cell surface (Edelberg, 1952).
There appears to be a surface preference for lipid-soluble substances, (Robertson,
1960); Van der Waals forces are thought to hold lipid molecules together to
protein side chains.
Pulvertaft (1946) has shown rhythmic movement or flicker on red cells, and
Weiss (1965) has suggested recently that the in vivo cell undergoes continuous
modification by sublethal autolysis, and that this autolysis is under endocrine
control. In support of this he has shown that rat fibroblasts treated with anti-
serum lose their acid phosphatase staining and become detached from glass
surfaces, and that both the loss of staining and tendency to detach are retarded
by hydrocortisone.
Rosenberg (1964) concurs with Weiss, and says the cell in equilibrium with the
environment modifies itself according to changes in the environment. He grew
human conjunctival cells at the interface between two liquids, one hydrophobic
and one hydrophilic, and found the cells grew in layers. However, when he added
lecithin, the cells grew in clumps.
Similarly, Sawant, Desai and Tappel (1964) have demonstrated binding of
enzymes to different sites on lysosomal membranes, and Bullough (1966) has
described feedback systems controlling the synthesis and activation of enzymes
by repressor molecules binding metabolites which, he believes, activate or
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Desai and Glover (1963) believe there is an association between the lipid
components of cell membranes and the permeability of the membranes, the
phospholipid content of which is genetically regulated and varies with the species.
The surface substance saponin or lysolecithin, which is produced by intracellular
phospholipase from lecithin, causes minute perforations in lipid membranes.
Bimolecular membranes may be damaged also by an accumulation of surface-
active anions, especially fatty acids which cause emulsification of the membranes.
It is thought the membranes may be reconstituted by the incorporation of surface-
active cations; Bangham, Rees and Shortlander (1962) have prevented liver
necrosis in rats subjected to carbon tetrachloride by the i.p. injection of cetyltri-
methylammonium bromide, which supports this hypothesis.
Lipids, too, play a complicated role in the functional activity of cell membranes.
On the one hand, they permit the passage oflipid-soluble drugs, while on the other
hand, they assist in maintaining the potassium balance of the cell (Coburn, 1963).
Shaprir and Kerpel (1964) have shown that triglycerides are in a state of balanced
synthesis which is under hormonal control, and Hotchkiss (1944) showed that
lipids protect the cell against metabolic effects of noxious agents which blocked
the potassium uptake in bacteria, and demonstrated that this is prevented by
cephalin; hence Gram-negative bacteria which contain cephalin are protected
from the effects of gramicidin. Similarly streptolysin inhibitors are associated
with A and B lipoproteins.
Disulphide bonds are also thought to play a part in the structure of gamma
globulin by linking the A and B chains (Cohen and Porter, 1964), and are believed
to be involved in the biological activity of proteins and peptides. Indeed the
activity of the hormone vasopressin in the toad has been shown by Schwarz (1959)
to depend on the presence of SS bonds, as the influence of the hormone in
increasing the permeability of the toad bladder is abolished if theSS bonds are
opened by SH reagents. Insulin is also believed to be similarly dependent on the
SS bond according to Rasmussin, Schwartz and Schoessler (1962): indeed it is
thought that all disulphide containing hormones have similar properties, and
other workers have isolated protein-steroid complexes and explored their anti-
genic properties, and it is believed that the protein steroid complexes mav act
as haptens, possibly with steroid specificity.
Kidson and Kirby (1964) believe that synthesis of RNA is under hormone
control, and that induction of enzyme synthesis by cortisone is regulated at the
level ofDNAtranscription tomessenger RNA. They found they could get altered
(and reversible) patterns ofmessenger RNA by either starvation or by the use of
hormones; most of the hormones they tested altered messenger RNA selectively,
increasing some fractions and diminishing others. They think that the hormones
act on genes by direct effect on the DNA-protein complex, possibly interacting
with repressor proteins, and that rapidly labelled RNA may act as repressor at
either the DNA or the ribosomal level. Sekeris and Karlson (1964) also think
that hormones activate the genes which produce messenger RNA, which in
turn leads to the synthesis of specific proteins. They found that the hypothesis,
that inhibitors of nucleic acid and protein biosynthesis also inhibit the activity
of hormones, is true for the larvae of Calliphora. Liao and Williams-Ashman
(1962) showed that the first effect of hormone is the production of messenger
RNA, as the action of the hormone is abolished by inhibitors of protein synthesis.
It is however unwise to over particularise regarding the action of hormones,
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in the light of the findings of Michael (1964) who investigated the distribution of
oestrogen after s.c. injection in the cat, and found uptake not only by the genital
tract but also by the pituitary, from where it localised in the septum and hypo-
thalamus. Nelson et al. (1964)have studies the hormonal steroids, and find that
a number of investigators (Taliaferro, Cobey and Leone, 1956; Wallace, Silver-
berg and Carter, 1957; Slaunwhite and Sandberg 1959) have demonstrated the
effect of corticosteroid-binding globulin on the metabolism of the corticosteroids
in pregnancy or patients receiving oestrogen, who have an increase in the bind-
ing proteins in the circulation with a resultant doubling or tripling of basal levels
of measurable corticosteroids. Despite the measurable levels of corticosteroid,
however, the material is thought to be biologically inactive in a bound state.
Nelson et al. (1964) conclude that oestrogens in human blood are in several forms,
mainly oestrogen sulphate, but there a-re also glucosiduronate conjugates, and
sulphoglucosidurate double conjugates, as well as free oestrogens. They found
that conjugation can occur in various tissues, which included foetal tissue as well
as the liver and intestinal mucosa.
On the other hand, Cope (1965) who has worked on adrenal steroids, has found
that they have a variable effect related to the concentration in the blood, the
metabolic state, and whether the steroids are in a protein-bound or free state. He
has recently suggested there may be separate binding sites for each steroid, and
that only the free steroid is normally active, and he believes that binding delays
steroid diffusion across membranes. Other workers (Erlanger et al., 1957
Beiser et al., 1959) believe that protein-steroid complexes can act as haptens. In
this connection the work of Movat and Fernando (1963) is relevant. They found
complexes formed without cell-binding, which can cause cellular injury and induce
an inflammatory response. It is possible therefore that some ranges of hormonal
imbalance may act as cellular irritants.
Riggs (1964) considers that hormones may enter cells by crossing the mem-
branes in a carrier state, and may be released again within the cell. He also
believes hormones can alter membranes to permit nutrients to enter. In support
of this. it is known that sodium moves out of a cell in response to insulin.
According to Coutinho (1965) many investigators believe that the mechanism
of action of steroid hormones is related to cytoplasmic enzyme-substrate reactions,
and steroid hormonal effects have been demonstrated in vitro in several enzy-
matic reactions (Villee, 1959; Engles, 1959; Talalay and Williams-Ashman,
1960), although no clear connection between these effects and the physiological
role of the hormones has been firmly established.
It has been shown by Csapo (1960) that modifications in the ionic environment
profoundly alter the properties of the excitable membrane of the uterine cell, and
the excitation process, which triggers the myoplasmic machinery, can be re-
versibly suppressed. It was also shown that the ovarian steroids alter the ionic
balance of the myometrial cell, and that such alterations modify its excitability
and pharmacological reactivity. Thus, it was proposed that the primary target
of the ovarian steroids is the myometrial cell membrane, and that the action of
these regulating agents is mediated by ions (Csapo, 1956).
This relationship between steroid hormones, ions and membrane function
operates not only in the regulation of myometrial function, for there is accumulat-
ing evidence (Tepperman and Tepperman, 1960) that other steroid hormones
also profoundly modify the ionic balance in mammals.
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Ions activate enzyme systems, and it is known that both calcium and mag-
nesium play a prominent role in carbohydrate. protein, and lipidsynthesis.
Indeed the balance between these two ions may regulate the reaction rates and, as
Dixon and Webb (1958) have suggested, ovarian hormones may actbv changing
the ionic state within the cell.They found that one of the results of oestrogen
treatment was an increase in divalent cations, especially calcium. in the cell
which, according to them, explains both the anabolic and the stimulating effect of
the hormone. They also found that progesterone prevented calcium entering
the cell, and magnesium dominated both the functioning of the cell membrane
and the metabolism of the cell. Heilbrunn (1956) showed that calcium alters the
viscosity ofprotoplasm when it enters a cell quickly, and increases the firmness of
the cortical area of the cell. Gent, Trounce and Walser (1964) have demonstrated
sites on human red cells which bind calcium ions. These sites are believed to be
either polyvalent, or a regular array of singly charged groups lying close together.
They are thought to be phosphate groups of phospholipids or polyphosphoino-
sitides with sialate groups onthe surface of the cell.
According to Jensen (1963) the three primary steroid sex hormones. oestradiol,
progesterone and testosterone, are only metabolised by the non-responsive tissues
which have a special affinity for them. As steroid oestrogens have a very high
affinity for some proteins, it is thought they may bind to A5 steroid isomerase an
hydroxysteroid dehydrogenases. Hormones could therefore not only exert a
positive or negative action by blocking growth-restraining factors, butthey could
accelerate enzyme function, or alter nuclear or cell membrane permeability, by
causing calcium binding.
The possibility should therefore be considered that hormones may have
varying effects according to the number of specificities which they have available
for interaction with a cell. Similarly, a cell under antibody attack could pre-
sumably respond atypically to a hormone if a number of the reactive cell sites
were already blocked by the antibody. Indeed Weir and Pinckard (1965) have
already demonstrated complement fixing antibodies against the mitochondria of
rat liver which had been previously damaged by carbon tetrachloride. These
antibodies were found to be transient, and it is not known whetherthey contribute
to tissue damage or are the result of an immune response to the damage; but
wlhether they are the result or the cause of the tissue damage, they could theoreti-
cally greatly modify the response of the cell to hormonal regulators.
Several variations from comparable normal cells have been described in
neoplasia. Rapport and Graf (1961) have found that tumour tissue contains
phospholipid haptens which are not found to any extent innon-malignant tissues.
They also obtained an antitumour gamma globulin which they demonstrated by
radio-active iodine, and found that complement and the specific antibody caused
a loss of free amino acid ribonucleotides and potassium from the target cell.
Glick and Githens (1964) have shown that tumour cells concentrate potassium
ions more efficiently than normal cells, and that removal of the sialic acid from
the cell surface inhibits this uptake.
Kalchar (1964) has found 4 types ofmalignant cells with a diminished capacity
to convert glucose to galactose compared to similar normal tissues. He believes
that the ability to synthesis galactose compounds may be insufficient tomaintain
cell surface polysaccharides, and this results in a loss of surface antigens in the
neoplastic cells.
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Electrophoresis has been used to study the structure of the cell surface.
Fuhrmann (1965) has worked with isolated liver parenchymal cells of various
inbred rat strains, and found little or no difference in the electrophoretic mobilities.
He found the electrophoretic mobility of rat liver proliferating after partial
hepatectomy correlated with the increased mitotic index which is found during
liver regeneration. However, it did not correlate with the diurnal variation in
normal liver mitotic index. He also found that when he treated proliferating
liver cells with neuraminidase the electrophoretic mobility was unchanged.
When, however, he treated hepatoma cells with neuraminidase there was a 50%0
reduction in the mobility which, he claimed, is evidence ofthe structural alteration
in the malignant cells. His findings may be summarised in his own words:
1.
" Proliferating as well as malignant liver cells of Wistar rats have higher
electrophoretic mobilities than the normal liver cells of the same strain.
2. ' A definite difference in electrophoretic mobility between proliferating liver
cells and malignant liver cells is found after treating both cell types with neura-
minidase; in both cases neuraminic acids are in the supernatant.
3. " After transferring the malignant liver ascites from Wistar to Sprague-
Dawley and BAL rats, the malignant cells retain the electrophoretic characteris-
tics of the donor strains.
4. "In vivo neuraminidase treatment ofrats harbouring amalignant liver ascites
and mice harbouring an Ehrlich ascites tumour, as well as in vitro treatment of
Hela-cell cultures affects neither the in vivo or the in vitro viability ofthese tumour
cells. "
Fuhrmann (1965) also found a variable between normal tissues after treat-
ment witlh neuraminidase. Rat kidney cells had a markedly increased electro-
phoretic mobility, whereas liver cells only showed a slight increase. He con-
siders this is due to secondary changes which may not occur as a result of the
enzyme treatment. Working on the same problem, Doljanski and Eisenberg
(1965) concluded from their experiments that the increase of mobility observed in
both malignant and regenerating cells was not directly associated with cell divi-
sion.
To clarify this question, the electrophoretic mobility of synchronised cultures
of Escherichia coli B. was examined in the laboratory of Schulman (1965). It was
found that cell samples, representing different stages in the mitotic cycle, all had
the same electrophoretic mobility. This observation is in line with findings of
Ruhenstroth-Bauer et al. (1962), according to which regenerating liver cells
exhibit the same increased mobility when measured during the troughs or the
peaks of the mitotic cycle. Similarly, measurements of Ehrlich ascites tumour
cells, even when effected in various phases of mitosis, showed a very small scatter
in mobility values (Cook, Heard and Seaman, 1962). Furthermore, as demon-
strated by Forrester, Ambrose and Macpherson (1962), polyoma induced malig-
nant cells manifested an increased charge when compared with normal cells with
the same rate of growth.
All these observations lead to the conclusion that the increased mobility
observed both in cells undergoing a regenerative growth process, as well as in
malignant cells, is not associated with the cell division cycle as such. The possi-
bility must be considered whether this increased mobility could be due to a tem-
porary increase ofsurface charge in the case ofregenerating cells, and a permanent
increase in malignant cells. Such an alteration in charge may be associated with
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an increased work potential, and an alteration in membrane permeability. The
alteration in permeability, if it occurs, would favour both regenerative and malig-
nant tissues as compared with normal cells in competition for nutrients.
These studies support the growing evidence of cell membrane involvement in
carcinogenesis, and study of the cytoplasm and its membranes in the develop-
ment and growth of cancer has been given additional impetus by thefindings of
McKinnell (1962) who has worked on the eggs of the frog Rana pipiens. He
activated the eggs, and removed the nucleus which he replaced with the nucleus
from disassociated renal adenocarcinoma cells from the Lucke tumour of frogs.
The experimental eggs developed to abnormal swimming forms, while the con-
trol eggs transplanted with normal blastula nuclei obtained complete metamor-
phosis. The interesting thing in these experiments is that a degree of organised
growth was obtained with malignant nuclear transplants. If the fundamental
lesion in cancer were nuclear, a mass of disorganised tissue would have been the
expected result of these transplant operations.
In tissue culture at any rate, direct contact between cells seems to exert some
effect, for Moller (1965) has shown that immune lymphocytes containing
histocompatible antigens ofthe F2 type exert a marked cytotoxic effecton tumour
cells incompatible with the H2 antigen. Also when he added either heat inacti-
vated rabbit serum or phytohaemagglutinin to a mixture of tumour cells, and
either allogeneic or semiallogeneic lymphocytes ofF1 hybrids which caused the
lymphocytes to aggregate around the tumour cells, he again obtained death of the
tumour cells, hence close contact with histoincompatible lymphocytes results in
death of the tumour cells.
Evidence is slowly mounting that antibody attack can so modify- the cell
that it responds atypically to hormonal regulators. If protein-steroid complexes
can also act as cell irritants and induce an inflammatory and antibody response,
there is a further possibility of atypical functioning of the cell membrane.
Allison, Smith and Wood (1955) have studied the effect of cortisone on the
cellular response to thermal injury, and concluded that cortisone exerts a direct
protective action on endothelial cells and leucocytes which renders them re-
fractory to the tissue products which initiate inflammation. This is a possible
explanation for the protective action of stress in delaying the onset of chemical
carcinogenesis which was found in this department (Anderson 1964). When this
observation is taken in conjunction with a previous finding of Anderson (1963)
that obliteration of the draining lymph nodes about an area of chemical carcino-
genesis by either thorotrast or local irradiation delays the onset of tumour
formation, we are again led back to the cell and its surfaces.
It would seem probable, therefore, that the cell surface is implicated in
carcinogenesis (Anderson and Green, 1963, 1965; Anderson, 1963, 1964) and
that there is an infinitely complicated interplay between undefnned locallv acting
forces and general circulatory regulators, both. of which express themselves in,
or on, the surface of the appropriate target cell.
This is, indeed, the logical conclusion to be drawn from Green's (1954) im-
munological theory ofcancer in which he suggests that morphostasis is maintained
by tissue specific antigen (TSA) and that when TSA is deleted or occluded by
auto-antibody attack the cell becomes autonomous. It would seem that lost
cell characteristics are not reconstituted at cell replication, but only at meiosis,
and that the mutation in stem cells, as postulated by Burch, Burwell and Rowell,
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(1965) is not an inevitable first step in carcinogenesis. If the lesion in carcino-
genesis is indeed in, or on, the cell surfaces, the occasional regression of meta-
stases after excision of the primary growth (Everson and Cole, 1956) also becomes
more explicable.
SUMMARY
Consideration of normal and neoplastic cell surfaces makes it seem probable
that the cell surface is implicated in carcinogenesis, and that lost cell characteris-
tics are not reconstituted at cell replication.
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